Antineoplastic and Immunomodulatory Effects of Cabozantinib in Continuous and Primary Human Anaplastic Thyroid Cancer Cells.
- DOI
- 10.3390/cancers18152379
- Published
- 2026 Jul 23
- Container
- Cancers
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/cancers18152379,
title = {Antineoplastic and Immunomodulatory Effects of Cabozantinib in Continuous and Primary Human Anaplastic Thyroid Cancer Cells.},
author = {Elia G and Ferrari SM and Balestri E and Botrini C and Ragusa F and Mazzi V and Rugani L and Piaggi S and Catania Romizi E and Fabrazzo O and Giorgetti E and Baglini A and Varricchi G and Virili C and Ulisse S and Materazzi G and Antonelli A and Fallahi P},
year = {2026},
journal = {Cancers},
doi = {10.3390/cancers18152379},
url = {https://doi.org/10.3390/cancers18152379}
}RIS
TY - JOUR TI - Antineoplastic and Immunomodulatory Effects of Cabozantinib in Continuous and Primary Human Anaplastic Thyroid Cancer Cells. AU - Elia G AU - Ferrari SM AU - Balestri E AU - Botrini C AU - Ragusa F AU - Mazzi V AU - Rugani L AU - Piaggi S AU - Catania Romizi E AU - Fabrazzo O AU - Giorgetti E AU - Baglini A AU - Varricchi G AU - Virili C AU - Ulisse S AU - Materazzi G AU - Antonelli A AU - Fallahi P PY - 2026 JO - Cancers DO - 10.3390/cancers18152379 UR - https://doi.org/10.3390/cancers18152379 ER -
APA
G, E., SM, F., E, B., C, B., F, R., V, M., L, R., S, P., E, C. R., O, F., E, G., A, B., G, V., C, V., S, U., G, M., A, A., & P, F. (2026). Antineoplastic and Immunomodulatory Effects of Cabozantinib in Continuous and Primary Human Anaplastic Thyroid Cancer Cells.. Cancers. https://doi.org/10.3390/cancers18152379
Source records
- pubmed · retrieved 2026-09-26T00:55:17.986Z